A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

被引：1
|
作者：
Rovithi, Maria
Labots, Marlette
Richard
Honeywell
Ten Tije, Albert J.
Ruijter, Rita
Skardhamar, Mikkjal
Peters, Godefridus J.
Voortman, Jens
Verheul, Henk M. W.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
  • [43] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [44] Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen
    Gerritse, S.
    ter Heine, R.
    Labots, M.
    van den Hombergh, E.
    Dekker, H.
    Lehutova, D.
    Rudek, M.
    van Erp, N.
    Verheul, H.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S19 - S19
  • [45] A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
    Rini, Brian I.
    Garcia, Jorge A.
    Cooney, Matthew M.
    Elson, Paul
    Tyler, Allison
    Beatty, Kristi
    Bokar, Joseph
    Mekhail, Tarek
    Bukowski, R. M.
    Budd, G. Thomas
    Triozzi, Pierre
    Borden, Ernest
    Ivy, Percy
    Chen, Helen X.
    Dolwati, Afshin
    Dreicer, Robert
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6277 - 6283
  • [46] Phase II trial of dose-escalated sorafenib in advanced solid tumors.
    Semrad, T. J.
    Eddings, C.
    Pan, C.
    Lau, D.
    Gandara, D. R.
    Beckett, L.
    Lara, P., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors
    Cooney, M. M.
    Garcia, J.
    Brell, J.
    Dreicer, R.
    Beatty, K.
    Mekhail, T.
    Bukowski, R.
    Zwiebel, J.
    Remick, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [50] A phase I and pharmacokinetic study of PEG-camptothecin in patients with advanced solid tumors.
    Hao, D
    Tolcher, AW
    Rizzo, JD
    Ochoa, L
    McCreery, H
    Schwartz, GH
    Patnaik, A
    Denis, LJ
    Hammond, LA
    Hidalgo, M
    Kwiatek, J
    McGuire, J
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4513S - 4513S
12345